Literature DB >> 19034704

Coronary artery disease screening in patients with diabetes.

Vincent Savarese1, Intekhab Ahmed, Barry J Goldstein.   

Abstract

Coronary artery disease (CAD) is the most common cause of death in patients with diabetes. Many diabetics have asymptomatic CAD, and may benefit from early diagnosis. We review the recent literature to evaluate whether the current evidence supports screening for CAD in asymptomatic diabetics. Currently, no single screening modality has shown sufficient accuracy to determine which patients will have significant CAD. The combination of imaging modalities may show promise in improving the accuracy of screening, and limited data suggest that screening in this population may be associated with improved outcomes. However, based on the current evidence we presently do not recommend screening for CAD in this population.

Entities:  

Mesh:

Year:  2008        PMID: 19034704     DOI: 10.1007/s12020-008-9083-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

1.  Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus.

Authors:  X Kang; D S Berman; H Lewin; R Miranda; J Erel; J D Friedman; A M Amanullah
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

2.  Relationship and prognostic value of coronary artery calcification by electron beam computed tomography to stress-induced ischemia by single photon emission computed tomography.

Authors:  Gautam Ramakrishna; Todd D Miller; Jerome F Breen; Philip A Araoz; David O Hodge; Raymond J Gibbons
Journal:  Am Heart J       Date:  2007-05       Impact factor: 4.749

3.  Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Authors:  John B Buse; Henry N Ginsberg; George L Bakris; Nathaniel G Clark; Fernando Costa; Robert Eckel; Vivian Fonseca; Hertzel C Gerstein; Scott Grundy; Richard W Nesto; Michael P Pignone; Jorge Plutzky; Daniel Porte; Rita Redberg; Kimberly F Stitzel; Neil J Stone
Journal:  Circulation       Date:  2006-12-27       Impact factor: 29.690

4.  Markers for silent myocardial ischemia in diabetes. Are they helpful?

Authors:  E Cosson; J R Attali; P Valensi
Journal:  Diabetes Metab       Date:  2005-04       Impact factor: 6.041

Review 5.  Ischemia imaging and plaque imaging in diabetes: complementary tools to improve cardiovascular risk management.

Authors:  Paolo Raggi; Antonio Bellasi; Carlo Ratti
Journal:  Diabetes Care       Date:  2005-11       Impact factor: 19.112

6.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

Authors:  Fiona Turnbull; Bruce Neal; Charles Algert; John Chalmers; Neil Chapman; Jeff Cutler; Mark Woodward; Stephen MacMahon
Journal:  Arch Intern Med       Date:  2005-06-27

7.  Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Authors:  R O Estacio; B W Jeffers; N Gifford; R W Schrier
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

8.  Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects.

Authors:  Wenchun Qu; Thuy T Le; Stanley P Azen; Min Xiang; Nathan D Wong; Terence M Doherty; Robert C Detrano
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

9.  Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.

Authors:  Frans J Th Wackers; Deborah A Chyun; Lawrence H Young; Gary V Heller; Ami E Iskandrian; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  Diabetes Care       Date:  2007-08-06       Impact factor: 19.112

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.